IP Library › Granted Patent US 6,972,187
Granted Patent B2
US 6,972,187 · App. 10/154,419 · Granted Dec 6, 2005

OAT5 molecules and uses therefor

Assignee: Millennium Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,972,187
App. No.
10/154,419
Granted
Dec 6, 2005
Kind
B2
Abstract

The invention provides isolated nucleic acids molecules, designated OAT5 nucleic acid molecules, which encode organic anion transporters. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing OAT5 nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a OAT5 gene has been introduced or disrupted. The invention still further provides isolated OAT5 polypeptides, fusion polypeptides, antigenic peptides and anti-OAT5 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.

Claims (20)

1. An isolated nucleic acid molecule selected from the group consisting of:

a) a nucleic acid molecule comprising a nucleotide sequence which is at least 95% identical to the nucleotide sequence of SEQ ID NO:7 or 9, wherein the nucleic acid molecule encodes a polypeptide having organic anion transporter (OAT) activity;

b) a nucleic acid molecule comprising a fragment of at least 1200 contiguous nucleotides of SEQ ID NO:7 or 9, wherein the fragment encodes a polypeptide having OAT activity;

c) a nucleic acid molecule which encodes a polypeptide comprising an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO:8, wherein the polypeptide has OAT activity; and

d) a nucleic acid molecule which encodes a fragment of a polypeptide comprising the amino acid sequence of SEQ ID NO:8, wherein the fragment comprises at least 400 contiguous amino acid residues of the amino acid sequence of SEQ ID NO:8 and has OAT activity.

2. An isolated nucleic acid molecule selected from the group consisting of:

a) a nucleic acid molecule comprising the nucleic acid sequence of SEQ ID NO:7 or SEQ ID NO:9;

b) a nucleic acid molecule consisting of the nucleic acid sequence of SEQ ID NO: 7 or SEQ ID NO:9;

c) a nucleic acid molecule which encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:8; and

d) a nucleic acid molecule which encodes a polypeptide consisting of the amino acid sequence of SEQ ID NO: 8.

3. The nucleic acid molecule of claim 1 , further comprising vector nucleic acid sequences.

4. The nucleic acid molecule of claim 2 , further comprising vector nucleic acid sequences.

5. The nucleic acid molecule of claim 1 , further comprising nucleic acid sequences encoding a heterologous polypeptide.

6. The nucleic acid molecule of claim 2 , further comprising nucleic acid sequences encoding a heterologous polypeptide.

7. An isolated host cell which contains the nucleic acid molecule of claim 3 .

8. The host cell of claim 7 which is a mammalian host cell.

9. An isolated host cell which contains the nucleic acid molecule of claim 4 .

10. The host cell of claim 9 which is a mammalian host cell.

11. A method for producing a polypeptide encoded by a nucleic acid molecule of claim 1 , comprising culturing a host cell containing the nucleic acid molecule of claim 1 under conditions in which the polypeptide is expressed, thereby producing the polypeptide.

12. A method for producing a polypeptide encoded by a nucleic acid molecule of claim 2 , comprising culturing a host cell containing the nucleic acid molecule of claim 2 under conditions in which the polypeptide is expressed, thereby producing the polypeptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2002
From: CURTIS, RORY A. J.; GLUCKSMANN, MARIA ALEXANDRA; MEYERS, RACHEL E.
To: MILLENNIUM PHARMACEUTICALS INC.
Reel/Frame 013251/0770 →
Continuity (23)
Continuation In Part 1005502500 · Jan 22, 2002
Continuation In Part 1002462300 · Dec 17, 2001
Continuation In Part 1000276900 · Nov 14, 2001
Continuation In Part 0997272400 · Oct 5, 2001
Continuation In Part 0996429500 · Sep 25, 2001
Continuation In Part 0995766400 · Sep 19, 2001
Continuation In Part 0991978100 · Jul 31, 2001
Continuation In Part 0989581100 · Jun 29, 2001
Continuation In Part 0985819400 · May 14, 2001
Provisional Application 6032401600 · Sep 20, 2001
Provisional Application 6026316900 · Jan 22, 2001
Provisional Application 6025802800 · Dec 21, 2000
Provisional Application 6025658800 · Dec 18, 2000
Provisional Application 6025624000 · Dec 15, 2000
Provisional Application 6024887800 · Nov 15, 2000
Provisional Application 6024836400 · Nov 15, 2000
Provisional Application 6023833600 · Oct 5, 2000
Provisional Application 6023510700 · Sep 25, 2000
Provisional Application 6023379000 · Sep 19, 2000
Provisional Application 6022176900 · Jul 31, 2000
Provisional Application 6021537600 · Jun 29, 2000
Provisional Application 6020421100 · May 12, 2000
Related Publication 20030143675A1 · Jul 31, 2003